PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
NCT06590194
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Interventions
DRUG:
PH009-1 tablet
Sponsor
Suzhou Puhe Pharmaceutical Technology Co., LTD